Literature DB >> 18404442

Adenosine A(1) receptor: Functional receptor-receptor interactions in the brain.

Kathrin Sichardt1, Karen Nieber.   

Abstract

Over the past decade, many lines of investigation have shown that receptor-mediated signaling exhibits greater diversity than previously appreciated. Signal diversity arises from numerous factors, which include the formation of receptor dimers and interplay between different receptors. Using adenosine A(1) receptors as a paradigm of G protein-coupled receptors, this review focuses on how receptor-receptor interactions may contribute to regulation of the synaptic transmission within the central nervous system. The interactions with metabotropic dopamine, adenosine A(2A), A(3), neuropeptide Y, and purinergic P2Y(1) receptors will be described in the first part. The second part deals with interactions between A(1)Rs and ionotropic receptors, especially GABA(A), NMDA, and P2X receptors as well as ATP-sensitive K(+) channels. Finally, the review will discuss new approaches towards treating neurological disorders.

Entities:  

Year:  2007        PMID: 18404442      PMCID: PMC2072922          DOI: 10.1007/s11302-007-9065-z

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  129 in total

1.  Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals.

Authors:  R A Cunha
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

Review 2.  Molecular physiology of P2 receptors in the central nervous system.

Authors:  Peter Illes; J Alexandre Ribeiro
Journal:  Eur J Pharmacol       Date:  2004-01-01       Impact factor: 4.432

Review 3.  Modulation of GABAA receptor activity by phosphorylation and receptor trafficking: implications for the efficacy of synaptic inhibition.

Authors:  Josef T Kittler; Stephen J Moss
Journal:  Curr Opin Neurobiol       Date:  2003-06       Impact factor: 6.627

4.  Role of P2 purinergic receptors in synaptic transmission under normoxic and ischaemic conditions in the CA1 region of rat hippocampal slices.

Authors:  Elisabetta Coppi; Anna Maria Pugliese; Holger Stephan; Christa E Müller; Felicita Pedata
Journal:  Purinergic Signal       Date:  2007-01-03       Impact factor: 3.765

5.  Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor.

Authors:  B Johansson; L Halldner; T V Dunwiddie; S A Masino; W Poelchen; L Giménez-Llort; R M Escorihuela; A Fernández-Teruel; Z Wiesenfeld-Hallin; X J Xu; A Hårdemark; C Betsholtz; E Herlenius; B B Fredholm
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

6.  Effects of SCH 58261, an adenosine A(2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake.

Authors:  P Popoli; R Reggio; A Pèzzola
Journal:  Neuropsychopharmacology       Date:  2000-05       Impact factor: 7.853

7.  Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium.

Authors:  Y Kohno; X Ji; S D Mawhorter; M Koshiba; K A Jacobson
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

8.  Effects of an A1 adenosine receptor agonist on the neurochemical, behavioral and histological consequences of ischemia.

Authors:  A Héron; D Lekieffre; E Le Peillet; F Lasbennes; J Seylaz; M Plotkine; R G Boulu
Journal:  Brain Res       Date:  1994-04-04       Impact factor: 3.252

9.  Agonist-promoted heteromeric oligomerization between adenosine A(1) and P2Y(1) receptors in living cells.

Authors:  Kazuaki Yoshioka; Osamu Saitoh; Hiroyasu Nakata
Journal:  FEBS Lett       Date:  2002-07-17       Impact factor: 4.124

10.  Focal deletion of the adenosine A1 receptor in adult mice using an adeno-associated viral vector.

Authors:  Thomas E Scammell; Elda Arrigoni; Margaret A Thompson; Patrick J Ronan; Clifford B Saper; Robert W Greene
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

View more
  12 in total

Review 1.  Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.

Authors:  Detlev Boison
Journal:  Epilepsy Res       Date:  2009-05-09       Impact factor: 3.045

2.  Interaction of purinergic receptors with GPCRs, ion channels, tyrosine kinase and steroid hormone receptors orchestrates cell function.

Authors:  Paola Scodelaro Bilbao; Sebastián Katz; Ricardo Boland
Journal:  Purinergic Signal       Date:  2011-09-02       Impact factor: 3.765

Review 3.  An essential role for adenosine signaling in alcohol abuse.

Authors:  Christina L Ruby; Chelsea A Adams; Emily J Knight; Hyung Wook Nam; Doo-Sup Choi
Journal:  Curr Drug Abuse Rev       Date:  2010-09

4.  Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors, and KATP channels.

Authors:  Masahito Kawamura; David N Ruskin; Susan A Masino
Journal:  J Neurosci       Date:  2010-03-17       Impact factor: 6.167

5.  3-Mercaptopropionic acid-induced repetitive seizures increase GluN2A expression in rat hippocampus: a potential neuroprotective role of cyclopentyladenosine.

Authors:  María Belén Gori; Elena Girardi
Journal:  Cell Mol Neurobiol       Date:  2013-06-08       Impact factor: 5.046

6.  Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture.

Authors:  Nanna Goldman; Michael Chen; Takumi Fujita; Qiwu Xu; Weiguo Peng; Wei Liu; Tina K Jensen; Yong Pei; Fushun Wang; Xiaoning Han; Jiang-Fan Chen; Jurgen Schnermann; Takahiro Takano; Lane Bekar; Kim Tieu; Maiken Nedergaard
Journal:  Nat Neurosci       Date:  2010-05-30       Impact factor: 24.884

7.  Electroacupuncture improves neuropathic pain: Adenosine, adenosine 5'-triphosphate disodium and their receptors perhaps change simultaneously.

Authors:  Wen Ren; Wenzhan Tu; Songhe Jiang; Ruidong Cheng; Yaping Du
Journal:  Neural Regen Res       Date:  2012-11-25       Impact factor: 5.135

8.  The P2X4 receptor is required for neuroprotection via ischemic preconditioning.

Authors:  Tomohiko Ozaki; Rieko Muramatsu; Miwa Sasai; Masahiro Yamamoto; Yoshiaki Kubota; Toshiyuki Fujinaka; Toshiki Yoshimine; Toshihide Yamashita
Journal:  Sci Rep       Date:  2016-05-13       Impact factor: 4.379

Review 9.  Sobriety and Satiety: Is NAD+ the Answer?

Authors:  Nady Braidy; Maria D Villalva; Sam van Eeden
Journal:  Antioxidants (Basel)       Date:  2020-05-14

Review 10.  G-Protein-Coupled Receptors and Ischemic Stroke: a Focus on Molecular Function and Therapeutic Potential.

Authors:  Zeinab Vahidinia; Mohammad Taghi Joghataei; Cordian Beyer; Mohammad Karimian; Abolfazl Azami Tameh
Journal:  Mol Neurobiol       Date:  2021-06-12       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.